NEW YORK (360Dx) – The new year continued its upward trajectory for many diagnostics firms' stocks in February as the 360Dx Index rose nearly 8 percent month over month.
This follows a strong January when the index was up 12 percent month over month.
The index outpaced the broader markets last month as the Dow Jones Industrial Average gained 4 percent month over month while the Nasdaq Composite and Nasdaq Biotech each ticked up 3 percent.